Associations of obesity and circulating insulin and glucose with breast cancer risk: a Mendelian randomization analysis
Xiang Shu(Memorial Sloan Kettering Cancer Center), Don Conroy(University of Cambridge), Qiuyin Cai(Vanderbilt University), Volker Arndt(German Cancer Research Center), Marjanka K. Schmidt(University of Cambridge), Hiltrud Brauch(German Cancer Research Center), Natalia Bogdanova(Medizinische Hochschule Hannover), Thomas Brüning(Institute for Prevention and Occupational Medicine), Jose E. Castelao(Servicio Gallego de Salud), Jenny Chang‐Claude(Universität Hamburg), Trinidad Caldés(Instituto de Investigación Sanitaria del Hospital Clínico San Carlos), Joe Dennis(University of Cambridge), Caroline Baynes(University of Cambridge), Georgia Chenevix‐Trench(QIMR Berghofer Medical Research Institute), Roger L. Milne(The University of Melbourne), Kyriaki Michailidou(Cyprus Institute of Neurology and Genetics), Myrto Barrdahl(German Cancer Research Center), Douglas F. Easton(University of Cambridge), Sara Y. Brucker(University Children's Hospital Tübingen), Irene L. Andrulis(University of Toronto), Sabine Behrens(German Cancer Research Center), Javier Benı́tez(Spanish National Cancer Research Centre), Beeghly-Fadiel Alicia, Christine L. Clarke(Memorial University of Newfoundland), Jacques Simard(Université Laval), Paul L. Auer(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Lang Wu(University of Hawaiʻi at Mānoa), Carl Blomqvist(University of Helsinki), Brian D. Carter(American Cancer Society), Louise A. Brinton(National Cancer Institute), Stig E. Bojesen(University of Copenhagen), Hermann Brenner(Universidad de Granada), Hoda Anton‐Culver(University of California, Irvine), Thomas J. Wang(Harvard University), Xiao‐Ou Shu(Vanderbilt University Medical Center), Laura E. Beane Freeman(National Cancer Institute), Paul D.P. Pharoah(Cedars-Sinai Medical Center), Ting‐Yuan David Cheng(The Ohio State University), Kristan J. Aronson(Queen's University), Nikhil K. Khankari(Vanderbilt University Medical Center), Wei Zheng(Vanderbilt University), Qin Wang(University of Cambridge), Barbara Burwinkel(German Cancer Research Center), Natalia Antonenkova(N.N. Alexandrov National Cancer Centre), Matthias W. Beckmann, David J. Hunter(Zhujiang Hospital), Per Broberg(German Cancer Research Center), Marina Bermisheva(Russian Academy of Sciences), Manjeet K. Bolla(University of Cambridge), Federico Canzian(German Cancer Research Center)
Cited by 115
Related Papers
Mutations of the BRAF gene in human cancer
|Nature|2002|10.7k
Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-years for 32 Cancer Groups, 1990 to 2015
|JAMA Oncology|2016|6.3k
Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease Study 2019
|The Lancet Public Health|2022|5.4k
Average Risks of Breast and Ovarian Cancer Associated with BRCA1 or BRCA2 Mutations Detected in Case Series Unselected for Family History: A Combined Analysis of 22 Studies
|The American Journal of Human Genetics|2003|3.7k